# Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026

Source: [News and press releases](https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-november-2026) · 2026-11-13 · Medicine
Page: https://themorning.science/story/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-1fc1c71701ec3555
Kind: other · Impact: low

## In brief

- The EMA's CHMP recommended seven new medicines for approval at its 9-12 November 2026 meeting.
- Meeting highlights were published by the EMA on 2026-11-13.
- Recommendations are non-binding; final marketing authorisation decisions rest with the European Commission.

## Why it matters

Science readers tracking European drug approvals can see which new treatments are moving toward authorisation in the EU, though the source provides no details on the individual medicines.

## Timeline

- 2026-11-09: CHMP meeting begins (9-12 November 2026)
- 2026-11-12: CHMP recommends seven new medicines for approval
- 2026-11-13: EMA publishes meeting highlights

## Coverage

- [Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026](https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-november-2026) — News and press releases, 2026-11-13

Tags: medicines, regulation, european medicines agency, drug approval, chmp

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science